Previous Article | Next Article 
Molecular and Cellular Biology, March 1999, p. 2373-2379, Vol. 19, No. 3
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Analysis of Genomic Integrity and p53-Dependent G1
Checkpoint in Telomerase-Induced Extended-Life-Span Human
Fibroblasts
Homayoun
Vaziri,1,*
Jeremy A.
Squire,2
Tej K.
Pandita,3
Grace
Bradley,2
Robert M.
Kuba,2
Haihua
Zhang,2
Sandor
Gulyas,2
Richard P.
Hill,2
Garry P.
Nolan,1 and
Samuel
Benchimol2
Department of Molecular Pharmacology,
Stanford University School of Medicine, Stanford, California
94305-53321; Ontario Cancer Institute
and Department of Medical Biophysics, University of Toronto, Toronto,
Ontario, M5G-2M9, Canada2; and
Center for Radiological Research, Columbia University, New
York, New York 100323
Received 2 November 1998/Accepted 9 December 1998
 |
ABSTRACT |
Life span determination in normal human cells may be regulated by
nucleoprotein structures called telomeres, the physical ends of
eukaryotic chromosomes. Telomeres have been shown to be essential for
chromosome stability and function and to shorten with each cell
division in normal human cells in culture and with age in vivo.
Reversal of telomere shortening by the forced expression of telomerase
in normal cells has been shown to elongate telomeres and extend the
replicative life span (H. Vaziri and S. Benchimol, Curr. Biol.
8:279-282, 1998; A. G. Bodnar et al., Science
279:349-352, 1998). Extension of the life span as a consequence of the
functional inactivation of p53 is frequently associated with loss of
genomic stability. Analysis of telomerase-induced
extended-life-span fibroblast (TIELF) cells by G banding and spectral
karyotyping indicated that forced extension of the life span by
telomerase led to the transient formation of aberrant structures, which
were subsequently resolved in higher passages. However, the
p53-dependent G1 checkpoint was intact as assessed by
functional activation of p53 protein in response to ionizing radiation
and subsequent p53-mediated induction of p21Waf1/Cip1/Sdi1.
TIELF cells were not tumorigenic and had a normal DNA strand break
rejoining activity and normal radiosensitivity in response to ionizing radiation.
 |
INTRODUCTION |
The finite life span of normal human
cells (16) is thought to be caused by the shortening of
telomeres. Telomeres are nucleoprotein structures that protect the ends
of eukaryotic chromosomes (4) and are composed of
tandem G-rich repeats maintained by telomerase, an RNA-protein complex
which synthesizes telomeric repeats de novo (9). Vertebrate
telomeres contain tandem (TTAGGG)n repeats (24) which are bound to a unique family of
telomere binding proteins (6). Due to incomplete replication
of the DNA termini (27), human somatic cells lose telomeric
DNA each time they divide (1, 11, 15, 33). The telomere
hypothesis proposes that the shortening of telomeres of one or
more chromosomes will eventually lead to senescence (10, 12,
27) and that the expression of telomerase activity in cancer
cells may be required for cell immortality (7, 19, 22).
In yeast and euplotes the catalytic domain subunit of telomerase is
required for in vivo telomere maintenance (20). The human
telomerase complex contains at least two components, the RNA template
component hTR (8) and a conserved catalytic subunit, hTERT
(13, 18, 21, 25).
Recently it has been shown that hTR and hTERT are sufficient for
reconstitution of telomerase activity (2, 35) and that forced expression of hTERT in normal human cells leads to
reconstitution of telomerase activity, telomere elongation, and
extended replicative potential (5, 32).
Normal human diploid fibroblasts are chromosomally stable during
most of their life span; however, near senescence they accumulate a
significant number of chromosomal aberrations, including a large number
of dicentric and ring chromosomes (3, 30). The extension of
the replicative life span and the bypass of senescence by DNA tumor
viruses or p53 alterations (28) are frequently associated with chromosomal instability (37) and the formation of
dicentric chromosomes near crisis (7). Resolution of these
aberrant structures is associated with reactivation of telomerase and
maintenance of telomeres (7). These findings suggest that
critical telomere shortening is associated with chromosomal instability
and that telomere elongation may be associated with chromosome
stabilization. Furthermore, telomerase has also been directly
implicated in the healing of broken chromosome ends (14, 23,
36). The unique phenomenon of life span extension by telomerase
enables us to use an isogenic system to directly test the role of
telomerase and telomeres in the maintenance of genomic integrity during
life span extension or the induction of DNA damage. Furthermore,
genomic stability in telomerase-induced extended-life-span fibroblast (TIELF) cells has significant implications for their use in cell- and
gene-based therapeutic strategies to overcome the senescence barrier in vivo.
In this work, we investigated the possibility that forced expression of
telomerase, leading to the generation of long telomeres and the
extension of the cellular life span, may result in genomic instability
and checkpoint-related defects in TIELF cells. Our results indicate
that TIELF cells are genetically stable, are nontumorigenic, have an
intact p53-dependent G1 checkpoint in response to DNA
damage, and can rejoin double-strand DNA breaks normally.
 |
MATERIALS AND METHODS |
Cell cultures and retroviral infections.
The BJ neonatal
human fibroblast cell strain was grown in
-minimal essential medium
supplemented with 10% fetal bovine serum, and viral infections with
pBabe and pBabest2 were performed as described previously
(32). The pBNhEST2HA virus was constructed by excision of
the EcoRI/SalI fragment of hTERT in plasmid
pCINeo-hEST2HA and its ligation into the pBabe plasmid backbone.
Plasmid pBA143 carried a dominant-negative mutant of p53 protein
(p53Ala143) which was subcloned into a pBabe-Ires-EGFP construct and
subsequently used to infect TIELF cells as described previously
(32). Fluorescence-activated cell sorter-sorted
EGFP+ cells were subsequently subjected to 6 Gy of
radiation and cell cycle analysis.
Comet assay.
Briefly, 2 × 104
exponentially growing cells were trypsinized, suspended in
phosphate-buffered saline (PBS), and irradiated on ice. After
irradiation an aliquot of 1.5 ml of 1% low-melting-point agarose held
at 50°C was added to the tube, and the suspension was rapidly
pipetted onto a glass microscope slide. For a neutral comet assay,
cells were lysed at 55°C for 2 h in buffer containing 30 mM EDTA
and 0.5% sodium dodecyl sulfate (pH 8.5) and were washed by submersion
in TBE buffer (90 mM Tris, 2 mM EDTA, 90 mM boric acid [pH 8.5]) for
3 h with three changes of buffer. This was followed by
electrophoresis in fresh TBE buffer at 0.6 V/cm for 25 min. Then the
slides were rinsed with distilled water and stained for 30 min in 2.5 µg of propidium iodide (PI)/ml.
The individual nuclei with broken DNA drawn out of the nucleus by
electrophoresis form "comet-like" structures. The comets were
digitized, and the tail moment was calculated as described elsewhere
(26) by Northern Eclipse software (Empix). One hundred comets from each sample were analyzed for each dose or time point. No
attempt was made to select comets, other than to avoid obvious debris
or comets that were spaced too closely or overlapped. The normalized
tail moment was used as a parameter to indicate DNA damage
(26). Three independent experiments were done, and the mean ± standard deviation was expressed in the final plot.
Radiation survival assay.
Cells were irradiated with
60Co gamma rays at a fractionated low dose rate of 0.025 Gy/min at 37°C. This dose was chosen to be low enough that repair of
radiation damage would be possible. Two million cells were grown in T75
flasks until they reached confluency. Following irradiation the cells
were held at 37°C for 24 h before being trypsinized, counted,
diluted, and plated for colony formation. Survival was calculated by
using the cell count obtained just prior to plating. The cells were
plated for a colony formation assay at three consecutive 10-fold
dilutions and then were incubated for 10 to 14 days before being
stained with methylene blue in 50% ethanol. Colonies containing more
than 50 cells were counted as survivors, and percent survival was
calculated as the ratio of plating efficiency for the treated group to
that for an untreated control.
Cell cycle analysis.
Cells were fixed with 70% ethanol,
washed in PBS, and resuspended in PBS with 0.12% Triton X-100-0.12 mM
EDTA containing 50 µg of RNase. After the addition of PI (at 50 µg/ml), the DNA content was measured without gating. The cell cycle
was quantitated by using the fully automated MODFIT program, and the
G1/S ratio was calculated. Results of three independent
experiments were averaged and plotted.
 |
RESULTS |
Analysis of telomeric DNA by terminal restriction fragment (TRF)
analysis and telomere fluorescent in situ hybridization (FISH).
TIELF cells were generated by infection of BJ cells (expressing
endogenous hTR) at population doubling (PD)50 with pBabest2 retrovirus
expressing hTERT as described previously (32). In this
experiment, BJ cells infected with the control virus (pBabe) senesced
at approximately PD 80. Hence, hTERT-expressing cells with PDs beyond
this value are considered TIELF cells. TIELF cells expressed the hTERT
protein when assayed by immunohistochemistry with a rabbit polyclonal
antibody (Fig. 1A). No staining was
observed in the parental strain expressing the control construct (Fig. 1B). A control pBNhEST2HA virus carrying a C-terminally tagged cDNA for
hTERT was also used in these experiments. This construct was unable to
elongate telomeres or extend the life span despite full reconstitution
of telomerase activity in BJ cells (data not shown). This indicates
that the hemagglutinin tag interferes with telomere elongation in vivo
and that telomerase activity per se is not sufficient for life span
extension.

View larger version (51K):
[in this window]
[in a new window]
|
FIG. 1.
hTERT staining of TIELF90 cells (A) and control BJ cells
(B). Confluent BJ and TIELF cells were fixed and stained with a
polyclonal rabbit antibody against hTERT by using the Vectastain ABC
system. A strong and punctate nuclear signal was evident in TIELF
cells.
|
|
Analysis of telomeric DNA in nontagged hTERT-expressing cells indicated
that after hTERT expression, the mean TRF length increased
at a rate of
approximately +116 bp/PD (average of two independent
experiments)
between PD 59 and PD 112. TIELF cells at PD 112 (TIELF112
cells) had a
mean TRF length of 16.8 ± 1 kb, which was comparable
to, and
slightly longer than, germ line (data not shown). Analysis
of mean TRF
length was performed by TeloRun Software (1, 7, 12,
33). Analysis of
telomeric DNA on individual telomeres by FISH
(Fig.
2) revealed that (i) young cells (Fig.
2A) have a substantially
more intense signal than old cells (Fig.
2B)
and (ii) the telomeric
signals on most chromosomes in TIELF cells are
more homogeneous
and intense than those on either young or old cells
(Fig.
2C).

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 2.
Analysis of telomeric DNA by telomere FISH during life
span extension of TIELF cells. Interphase telomeres were analyzed by
telomere FISH with superimposed 4',6-diamidino-2-phenylindole (DAPI)
staining. The telomere signal intensity diminished with increasing
passages and was significantly restored in TIELF cells. Young BJ31 (A),
old BJ78 (B), and TIELF (C) cells were grown on the same chamber slide.
A telomere-specific probe (Oncor) was used to detect
(TTAGGG)n repeats as previously described
(17) and according to Oncor's protocols.
|
|
Chromosomal stability in TIELF cells.
The question of
chromosomal stability in TIELF cells was addressed by cytogenetic
G-banding analysis of metaphase chromosomes in mass cultures of young
control BJ31 cells (BJ cells at PD31, without telomerase activity),
BJ66 cells (telomerase-positive cells at PD 66; TRF length, 11.9 ± 0.8 kbp), TIELF92 cells (TRF length, 14.1 ± 0.6 kbp), and
TIELF140 cells. Analysis of metaphase spreads by G banding revealed no
significant differences between BJ31, BJ66 (n = 1 of
105), and TIELF cells (n = 4 of 94; 50 of these
metaphases were obtained from TIELF140 cells) (P = 0.2
by a two-tailed Fisher's exact test). All aberrations were found in
TIELF92 cells (4 of 44), and no aberrations were found in TIELF140 cells (0 of 50). Comparison of TIELF92 aberrations (4 of 44) to aberrations in control BJ cells (0 of 55) by Fisher's exact test showed a significant difference (P = 0.036). However,
no further aberrations or significant differences were observed when
TIELF cells were passaged further (aberrations were found in 0 of 50 TIELF140 cells versus 1 of 50 BJ31 cells). (The nonclonal chromosomal aberrations which were detected in TIELF92 cells included 5p+, 2q+, and
balanced translocation t(12;14) (Fig. 3).
A more detailed analysis of possible chromosomal aberrations was
performed by spectral karyotyping (SKY) (29). This analysis
uses colored fluorescent chromosome-specific paints that provide a
complete analysis of the human chromosomal complement. Thus,
chromosomal rearrangements can be identified by the juxtaposition of
different colors along a single chromosome. The SKY analysis confirmed
the results of the G-banding analysis (Fig. 3) and revealed one
additional structural change, 12p
, in TIELF cells (SKY analysis is
more sensitive than G banding). Even with the addition of this new aberration to our previous data set, no significant statistical difference between BJ (n = 1 of 105) and TIELF
(n = 5 of 94) cells was present (P = 0.1 by a two-tailed Fisher's exact test). None of the aberrations
detected were identical, and hence they do not represent clonal
changes. The frequency of aberrations found in TIELF cells (5%) is
comparable to that in other normal fibroblast strains (3 to 8%)
(37). We also analyzed numerical changes as a measure of
chromosomal stability, using a chr8-specific centromeric probe (D8Z2;
Vysis Inc) by interphase FISH analysis. Analysis of 400 cells from each
strain (1,200 total) did not reveal any evidence of aneuploidy.
Percentages of aneuploid cells were as follows: for BJ31 cells, 7%;
for BJ66 cells, 8%; and for TIELF cells, 5%). Further analysis of two
independent clones from our previous studies (32) (TIELF
clone 1 and TIELF clone 2) at PD 154 by G banding (n = 50) revealed 3 and 4% aberrant chromosomes, frequencies
comparable to that in young BJ31 cells (3%).

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 3.
G-banding and SKY analyses of metaphases from TIELF
cells containing a t(12;14) translocation (arrow) and other
aberrations. Structural chromosome aberrations were detected in
metaphases from TIELF cultures. Cells were grown as described elsewhere
(32) and were split 1:16 in growth medium without G418 for
24 h before any treatment. Well-spread G-banded metaphases (550 band level) from BJ31, BJ66, and TIELF strains were analyzed. These
were coded prior to analysis and scored double-blind. (A) G banding of
the t(12;14). (B and C) SKY analysis of the t(12;14). (D) SKY and G
banding of cells shown in panel A. (E) 2q+, structural aberration shown
by the solid bar. (F) 5p+ aberration. (G) 12p deletion. A SKY
hybridization and detection kit (SD-200 Bio system; Applied Spectral
Imaging Inc.) was used to visualize all human chromosomes in 23 to 24 colors. Chromosomes were analyzed by a combination of Fourier
spectroscopy, charge-coupled device imaging, and computerization to
excite and measure the emission spectra simultaneously for all dyes in
the spectral range and from all points in the metaphase spread
(29). Images were analyzed by using SKYVIEW software.
|
|
DNA strand break rejoining activity and radiation sensitivity are
intact in TIELF cells.
To determine if TIELF cells have a
deficiency in DNA repair, the following experiments were performed.
TIELF and BJ31 control cells were exposed to increasing doses of
ionizing radiation (0 to 30 Gy), and DNA strand breaks and rejoining
were analyzed by the comet assay (26). There was a linear
relationship between the tail moment (a measure of the DNA
double-strand breaks) and the radiation dose, and this relationship was
identical in BJ31 and TIELF cells (Fig.
4A). Cells were tested for their ability to rejoin DNA double-strand breaks following 10 Gy of ionizing radiation. The normalized tail moments, measured at different times
after irradiation, were identical in BJ31 and TIELF cells (Fig. 4B).
Similar results were also obtained for single-strand break rejoining
(data not shown).

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 4.
Responses of BJ31 and TIELF cells to ionizing radiation:
generation of DNA double-strand breaks (A), rejoining kinetics of
double-strand breaks (B), and clonogenic survival after low-dose rate
irradiation (C). In all assays BJ31 and TIELF cells behave identically.
(A) Ionizing radiation dose versus tail moment of BJ31 and TIELF cells
as measured immediately after irradiation by the neutral comet assay.
(B) Mean tail moment as a function of time after a dose of 10 Gy in
BJ31, TIELF, and positive-control CHO511 cells (Ku-70 deficient), which
have impaired DNA repair and show higher tail moments. (C) Clonogenic
survival as a function of ionizing radiation dose. Cells were
irradiated with 60Co gamma rays at a low dose rate of 0.025 Gy/min at 37°C. This dose rate was chosen to be low enough that cell
survival could be influenced by repair of radiation damage occurring
during the treatment. Two million cells were grown to confluency.
Following irradiation the cells were held at 37°C for 24 h
before being trypsinized, counted, diluted, and plated for colony
formation. Survival was calculated by using the cell count obtained
just prior to plating. The cells were plated for a colony formation
assay and then incubated for 10 to 14 days before being stained.
Colonies containing more than 50 cells were counted. Survival was
expressed as the ratio of the plating efficiency of the irradiated
cells to that of control cells.
|
|
Finally, we used continuous low-dose ionizing radiation to measure
long-term clonogenic survival and relative radiosensitivities.
There
was no difference between the survival of BJ31 cells and
that of TIELF
cells at these biologically relevant doses of ionizing
radiation (Fig.
4C).
Preserved radiation-induced p53-dependent G1 checkpoint
and lack of tumorigenicity in TIELF cells.
To determine if the DNA
damage G1 checkpoint was retained in TIELF cells, cell
cycle analysis was performed 24 h after exposure to 6 Gy of
ionizing radiation, and the results of three experiments were obtained
(Fig. 5). Both the BJ31 and the TIELF
cells undergo a G1 arrest as measured by the increased
G1/S ratio. There was no significant difference in the
G1/S ratio between the two cell strains (G1/S ratios, 10 for BJ cells and 11 for TIELF cells). Therefore the radiation-induced
G1 checkpoint appears to be intact in both strains.
Consistent with the wild-type function of p53 protein in their parental
BJ cells (34), TIELF cells were able to induce p53 protein
(Fig. 5B) in response to 6 Gy of ionizing radiation and to upregulate
its major downstream transcriptional target,
p21Waf1/Cip1/Sdi1 (Fig. 5D). Since simple
upregulation of the p53 protein level in response to DNA damage is not
a measure of its functionality, we measured the specific DNA binding
activity of p53 protein by an electromobility shift assay (EMSA)
(34). After normalization of the increased level of p53
protein postradiation to that of unirradiated cells, EMSA was performed
and detected an increase in the specific activity of p53 protein
independent of its level in both BJ31 and TIELF cells (Fig. 5C). The
increase in the specific DNA binding activity of p53 protein was
sufficient to upregulate p21Waf1/Cip1/Sdi1
protein (Fig. 5D) in both strains. This induction was p53 dependent, since expression of a dominant-negative form of p53 protein in TIELF
cells (p53Ala143) was able to reduce its DNA binding activity and led
to reduced induction of p21Waf1/Cip1/Sdi1 (Fig. 5D) and a
decreased G1/S ratio (Fig. 5A).

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 5.
(A) Cell cycle analysis of BJ31 and TIELF cells in
response to ionizing radiation. Cells were fixed with 70%
ethanol, washed in PBS, and resuspended in PBS with 0.1% Triton
X-100-0.12 mM EDTA containing 50 µg of RNase. After the addition of
PI (50 µg/ml), the DNA content was measured without
gating. The cell cycle was quantitated by using the fully
automated MODFIT program, and the G1/S ratio was
calculated. Solid bar, untreated BJ31 cells;crosshatched
bar, BJ31 cells exposed to 6 Gy of ionizing radiation; open bar,
untreated TIELF cells; hatched bar, TIELF cells exposed to 6 Gy of
ionizing radiation; stippled bar, TIELF cells carrying pBA143, a
dominant-negative form of p53, exposed to 6 Gy of ionizing radiation.
Results of three experiments were pooled, and the means and standard
deviations were plotted. (B) Western blot of p53 and beta-tubulin
(B-Tub) proteins. TIELF and BJ cells were exposed to 6 Gy of ionizing
radiation. Three hours postradiation, equal amounts of protein lysate
were resolved and p53 protein was detected with a DO-1
antibody as previously described (34). A beta-tubulin
antibody was used as a loading control. (C) DNA binding activity of p53
protein as measured by an EMSA as described previously (34).
(D) Western blot analysis of p21Waf1/Cip1/Sdi1 as
measured by an SC-817 antibody.
|
|
We investigated as well the tumorigenic potential of TIELF cells by
injection of 2 × 10
6 BJ31 and TIELF cells into the
leg muscles of six CB17
scid mice.
No tumors were formed
after 160
days.
 |
DISCUSSION |
It has been proposed that telomere shortening during replicative
aging of normal cells eventually generates antiproliferative signals
which activate p53 protein and subsequent G1 arrest,
observed at senescence (34). In the presence of factors,
such as simian virus 40 large T antigen (SV40LT) or E6, which are known
to bind and inactivate p53 protein, the telomere-shortening signal is bypassed, leading to more telomere shortening and extension of the life
span and subsequent genomic instability (7). Extension of
the life span by forced telomerase expression, however, may be
fundamentally different from that of SV40LT or other DNA tumor viruses.
Telomerase expression prevents the antiproliferative signal
generated by telomere shortening at senescence, possibly by telomere
elongation. We suggest that prevention of the p53-mediated antiproliferative signal in response to telomere shortening allows cells to divide further. Extension of the life span by SV40LT, however,
relies on inactivation of p53 and pRb proteins, and telomere shortening
continues to persist until crisis. This suggests that life span
extension by forced telomerase expression may not interfere with the
p53-dependent signaling pathway, and therefore TIELF cells would retain
their genomic integrity (31) at least by 60 PD postsenescence.
Cytogenetic analysis of TIELF cells by G-banding and SKY analyses
revealed that at PD92 TIELF cells have a significantly higher number of
aberrations than their young parental BJ cells. However, subsequent
passaging of TIELF cells to PD 140 led to resolution of these nonclonal
aberrations. The molecular mechanism behind the formation and
resolution of these aberrations is not clear. The number of aberrations
in TIELF cells was also measured by using a chr8-specific centromeric
probe by interphase FISH of 400 TIELF cells and 800 control cells. We
were unable to detect a significant number of aberrations compared to
that in controls. In agreement with these results, TIELF cells had an
intact p53-dependent G1 checkpoint in response to ionizing
radiation as measured by four criteria: (i) an increased
G1/S ratio postradiation, (ii) increased levels of both p53
protein and its specific DNA binding activity, (iii) increased levels
of p21Waf1/Cip1/Sdi1, the downstream target of p53 protein,
and (iv) the abrogation of the G1 checkpoint and the
reduction of p53 protein activity and of the level of
p21Waf1/Cip1/Sdi1 by dominant-negative expression of
p53Ala143 in TIELF cells.
Telomerase is able to elongate DNA termini that are not complementary
to its RNA template sequence (14) and is implicated in
the healing of chromosome breaks in alpha thalassemia (14, 23,
36) by direct addition of (TTAGGG)n
repeats to stabilize the ends. To investigate the probability
that telomerase is involved in the repair of double-strand DNA breaks
in response to DNA damage, we subjected telomerase-negative BJ cells
and TIELF cells to varying doses of ionizing radiation; we then
measured the DNA strand break rejoining ability of these cells by
the comet assay and their radiosensitivity by a long-term colony
survival assay. We were unable to detect a measurable difference
in survival between BJ and TIELF strains. Although one cannot rule out
the possibility that telomerase is involved in the addition of
(TTAGGG)n repeats to sites of
double-strand breaks, we cannot detect a measurable physiological
difference between the two cell strains in the presence or absence of
telomerase in response to ionizing radiation. Furthermore, these
results indicate that extension of the life span does not affect DNA
strand rejoining activity or long-term survival of cells in response to
DNA damage.
We conclude on the basis of five criteria, cytogenetic analysis,
radiation sensitivity, DNA break rejoining activity,
radiation-induced p53-dependent G1 checkpoint, and
tumorigenicity, that TIELF cells appear similar to their normal young
counterparts. The preservation of a normal phenotype in TIELF
cells makes it possible to generate difficult-to-establish cell strains
for further genetic alterations and manipulation by homologous targeted
recombination. These modified cells can further be used for different
cell and gene therapy applications to overcome potential senescence in vivo.
 |
ACKNOWLEDGMENTS |
This work was supported by the Medical Research Council of Canada
and the National Cancer Institute of Canada.
We thank Robert Weinberg for pCI-Neo-hEST2HA and Solomon Minkin for
help with statistical analysis.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Stanford
University School of Medicine, Department of Molecular Pharmacology,
Edward's Building, 300 Pasteur Dr., Stanford, CA 94305-5332. Phone: (650) 498-4398. Fax: (650) 725-2952. E-mail:
vaziri{at}cmgm.stanford.edu.
 |
REFERENCES |
| 1.
|
Allsopp, R. C.,
H. Vaziri,
C. Patterson,
S. Goldstein,
E. V. Younglai,
A. B. Futcher,
C. W. Greider, and C. B. Harley.
1992.
Telomere length predicts replicative capacity of human fibroblasts.
Proc. Natl. Acad. Sci. USA
89:10114-10118[Abstract/Free Full Text].
|
| 2.
|
Beattie, T. L.,
W. Zhou,
M. O. Robinson, and L. Harrington.
1998.
Reconstitution of human telomerase activity in vitro.
Curr. Biol.
8:177-180[Medline].
|
| 3.
|
Benn, P.
1976.
Specific chromosome alterations in senescent fibroblast cell lines derived from human embryos.
Am. J. Hum. Genet.
28:465-473[Medline].
|
| 4.
|
Blackburn, E. H., and C. W. Greider.
1995.
Telomeres.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 5.
|
Bodnar, A. G.,
M. Ouellette,
M. Frolkis,
S. E. Holt,
C. Chiu,
G. B. Morin,
C. B. Harley,
J. W. Shay,
S. Lichtsteiner, and W. E. Wright.
1998.
Extension of life-span by introduction of telomerase into normal human cells.
Science
279:349-352[Abstract/Free Full Text].
|
| 6.
|
Chong, L.,
B. van Steensel,
D. Broccoli,
H. Erdjument,
J. Hanish,
P. Tempst, and T. de Lange.
1995.
A human telomeric protein.
Science
270:1663-1667[Abstract/Free Full Text].
|
| 7.
|
Counter, C. M.,
A. A. Avilion,
C. E. LeFeuvre,
N. G. Stewart,
C. W. Greider,
C. B. Harley, and S. Bacchetti.
1992.
Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity.
EMBO J.
11:1921-1929[Medline].
|
| 8.
|
Feng, J.,
W. D. Funk,
S. Wang,
S. L. Weinrich,
A. A. Avilion,
C. Chiu,
R. R. Adams,
E. Chang,
R. C. Allsopp,
J. Yu,
L. Siyuan,
M. D. West,
C. B. Harley,
W. H. Andrews,
C. W. Greider, and B. Villeponteau.
1995.
RNA component of human telomerase.
Science
269:1236-1241[Abstract/Free Full Text].
|
| 9.
|
Greider, C. W., and E. H. Blackburn.
1985.
Identification of a specific telomere terminal transferase activity in Tetrahymena extracts.
Cell
43:405-413[Medline].
|
| 10.
|
Harley, C. B.
1991.
Telomere loss: mitotic clock or genetic time bomb?
Mutat. Res.
256:271-282[Medline].
|
| 11.
|
Harley, C. B.,
A. B. Futcher, and C. W. Greider.
1990.
Telomeres shorten during ageing of human fibroblasts.
Nature
345:458-460[Medline].
|
| 12.
|
Harley, C. B.,
H. Vaziri,
C. M. Counter, and R. C. Allsopp.
1992.
The telomere hypothesis of cellular aging.
Exp. Gerontol.
27:375-382[Medline].
|
| 13.
|
Harrington, L.,
W. Zhou,
T. McPhail,
R. Oulton,
D. S. Yeung,
V. Mar,
M. B. Bass, and M. O. Robinson.
1997.
Human telomerase contains evolutionarily conserved catalytic and structural subunits.
Genes Dev.
11:3109-3115[Abstract/Free Full Text].
|
| 14.
|
Harrington, L. A., and C. W. Greider.
1991.
Telomerase primer specificity and chromosome healing.
Nature
353:451-454[Medline].
|
| 15.
|
Hastie, N. D.,
M. Dempster,
M. G. Dunlop,
A. M. Thompson,
D. K. Green, and R. C. Allshire.
1990.
Telomere reduction in human colorectal carcinoma and with ageing.
Nature
346:866-868[Medline].
|
| 16.
|
Hayflick, L., and P. Moorhead.
1961.
The serial cultivation of human diploid strains.
Exp. Cell Res.
25:585-621.
|
| 17.
|
Henderson, S.,
R. C. Allsopp,
D. Spector,
S. Wang, and C. B. Harley.
1996.
In situ analysis of changes in telomere size during replicative aging and cell transformation.
J. Cell Biol.
134:1-12[Abstract/Free Full Text].
|
| 18.
|
Kilian, A.,
D. L. Bowtell,
H. E. Abud,
G. R. Hime,
D. J. Venter,
P. K. Keese,
E. L. Duncan,
R. R. Reddel, and R. A. Jefferson.
1997.
Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types.
Hum. Mol. Genet.
6:2011-2019[Abstract/Free Full Text].
|
| 19.
|
Kim, N. W.,
M. A. Piatyszek,
K. R. Prowse,
C. B. Harley,
M. D. West,
P. L. Ho,
G. M. Coviello,
W. E. Wright,
S. L. Weinrich, and J. W. Shay.
1994.
Specific association of human telomerase activity with immortal cells and cancer.
Science
266:2011-2015[Abstract/Free Full Text].
|
| 20.
|
Lingner, J.,
T. R. Hughes,
A. Shevchenko,
M. Mann,
V. Lundblad, and T. R. Cech.
1997.
Reverse transcriptase motifs in the catalytic subunit of telomerase.
Science
276:561-567[Abstract/Free Full Text].
|
| 21.
|
Meyerson, M.,
C. M. Counter,
E. Ng Eaton,
L. W. Ellisen,
P. Steiner,
S. D. Caddle,
L. Ziaugra,
R. L. Beijersbergen,
M. J. Davidoff,
Q. Liu,
S. Bacchetti,
D. A. Haber, and R. A. Weinberg.
1997.
hEST2, the putative human telomerase catalytic subunit gene, is upregulated in tumor cells and during immortalization.
Cell
90:785-795[Medline].
|
| 22.
|
Morin, G. B.
1989.
The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats.
Cell
59:521-529[Medline].
|
| 23.
|
Morin, G. B.
1991.
Recognition of a chromosome truncation site associated with alpha-thalassaemia by human telomerase.
Nature
353:454-456[Medline].
|
| 24.
|
Moyzis, R. K.,
J. M. Buckingham,
L. S. Cram,
M. Dani,
L. L. Deaven,
M. D. Jones,
J. Meyne,
R. L. Ratliff, and J. R. Wu.
1988.
A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes.
Proc. Natl. Acad. Sci. USA
85:6622-6626[Abstract/Free Full Text].
|
| 25.
|
Nakamura, T. M.,
G. B. Morin,
K. B. Chapman,
S. L. Weinrich,
W. H. Andrews,
J. Lingner,
C. B. Harley, and T. R. Cech.
1997.
Telomerase catalytic subunit homologs from fission yeast and human.
Science
277:955-959[Abstract/Free Full Text].
|
| 26.
|
Olive, P. L.,
J. P. Banath, and R. E. Durand.
1990.
Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the "comet assay."
Radiat. Res.
122:86-94[Medline].
|
| 27.
|
Olovnikov, A. M.
1971.
A theory of marginotomy.
Dokl. Biochem.
201:394-397.
|
| 28.
|
Rogan, E. M.,
T. M. Bryan,
B. Hukku,
K. Maclean,
A. C. Chang,
E. L. Moy,
A. Englezou,
S. G. Warneford,
L. Dalla-Pozza, and R. R. Reddel.
1995.
Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts.
Mol. Cell. Biol.
15:4745-4753[Abstract].
|
| 29.
|
Schrock, E.,
S. du Manoir,
T. Veldman,
B. Schoell,
J. Weinberg,
M. A. Ferguson,
Y. Ning,
D. H. Ledbetter,
I. Bar-Am,
D. Soeksen,
Y. Garini, and T. Ried.
1996.
Multicolor spectral karyotyping of human chromosomes.
Science
273:494-497[Abstract].
|
| 30.
|
Sherwood, S. W.,
D. Rush,
J. L. Ellsworth, and R. T. Schimke.
1988.
Defining cellular senescence in IMR-90 cells: a flow cytometric analysis.
Proc. Natl. Acad. Sci. USA
85:9086-9090[Abstract/Free Full Text].
|
| 31.
|
Vaziri, H.
1998.
Extension of life span by telomerase activation: a revolution in cultural senescence.
J. Anti-Aging Med.
1:125-130.
|
| 32.
|
Vaziri, H., and S. Benchimol.
1998.
Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span.
Curr. Biol.
8:279-282[Medline].
|
| 33.
|
Vaziri, H.,
F. Schachter,
I. Uchida,
L. Wei,
X. Zhu,
R. Effros,
D. Cohen, and C. B. Harley.
1993.
Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes.
Am. J. Hum. Genet.
52:661-667[Medline].
|
| 34.
|
Vaziri, H.,
M. D. West,
R. C. Allsopp,
T. S. Davison,
Y. S. Wu,
C. H. Arrowsmith,
G. G. Poirier, and S. Benchimol.
1997.
ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the posttranslational activation of p53 protein involving poly(ADP-ribose) polymerase.
EMBO J.
16:6018-6033[Medline].
|
| 35.
|
Weinrich, S.,
L., R. Pruzan,
L. Ma,
M. Ouellette,
V. M. Tesmer,
S. E. Holt,
A. G. Bodnar,
S. Lichtsteiner,
N. W. Kim,
J. B. Trager,
R. D. Taylor,
R. Carlos,
W. H. Andrews,
W. E. Wright,
J. W. Shay,
C. B. Harley, and G. B. Morin.
1997.
Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT.
Nat. Genet.
17:498-502[Medline].
|
| 36.
|
Wilkie, A. O.,
J. Lamb,
P. C. Harris,
R. D. Finney, and D. R. Higgs.
1990.
A truncated human chromosome 16 associated with alpha thalassaemia is stabilized by addition of telomeric repeats (TTAGGG)n.
Nature
346:868-871[Medline].
|
| 37.
|
Wolman, S. R.,
K. Hirschhorn, and G. J. Todaro.
1964.
Early chromosomal changes in SV40-infected human fibroblast cultures.
Cytogenetics
3:45-61.
|
Molecular and Cellular Biology, March 1999, p. 2373-2379, Vol. 19, No. 3
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Gillies, R. J., Robey, I., Gatenby, R. A.
(2008). Causes and Consequences of Increased Glucose Metabolism of Cancers. JNM
49: 24S-42S
[Abstract]
[Full Text]
-
Mahale, A. M., Khan, Z. A.T., Igarashi, M., Nanjangud, G. J., Qiao, R. F., Yao, S., Lee, S. W., Aaronson, S. A.
(2008). Clonal Selection in Malignant Transformation of Human Fibroblasts Transduced with Defined Cellular Oncogenes. Cancer Res.
68: 1417-1426
[Abstract]
[Full Text]
-
Schreurs, M. W. J., Hermsen, M. A. J. A., Geltink, R. I. K., Scholten, K. B. J., Brink, A. A. T. P., Kueter, E. W. M., Tijssen, M., Meijer, C. J. L. M., Ylstra, B., Meijer, G. A., Hooijberg, E.
(2005). Genomic stability and functional activity may be lost in telomerase-transduced human CD8+ T lymphocytes. Blood
106: 2663-2670
[Abstract]
[Full Text]
-
Krikun, G., Mor, G., Alvero, A., Guller, S., Schatz, F., Sapi, E., Rahman, M., Caze, R., Qumsiyeh, M., Lockwood, C. J.
(2004). A Novel Immortalized Human Endometrial Stromal Cell Line with Normal Progestational Response. Endocrinology
145: 2291-2296
[Abstract]
[Full Text]
-
Scott, L. A., Vass, J. K., Parkinson, E. K., Gillespie, D. A. F., Winnie, J. N., Ozanne, B. W.
(2004). Invasion of Normal Human Fibroblasts Induced by v-Fos Is Independent of Proliferation, Immortalization, and the Tumor Suppressors p16INK4a and p53. Mol. Cell. Biol.
24: 1540-1559
[Abstract]
[Full Text]
-
Sharma, G. G., Hwang, K.-k., Pandita, R. K., Gupta, A., Dhar, S., Parenteau, J., Agarwal, M., Worman, H. J., Wellinger, R. J., Pandita, T. K.
(2003). Human Heterochromatin Protein 1 Isoforms HP1Hs{alpha} and HP1Hs{beta} Interfere with hTERT-Telomere Interactions and Correlate with Changes in Cell Growth and Response to Ionizing Radiation. Mol. Cell. Biol.
23: 8363-8376
[Abstract]
[Full Text]
-
Patry, C., Bouchard, L., Labrecque, P., Gendron, D., Lemieux, B., Toutant, J., Lapointe, E., Wellinger, R., Chabot, B.
(2003). Small Interfering RNA-Mediated Reduction in Heterogeneous Nuclear Ribonucleoparticule A1/A2 Proteins Induces Apoptosis in Human Cancer Cells but not in Normal Mortal Cell Lines. Cancer Res.
63: 7679-7688
[Abstract]
[Full Text]
-
Milyavsky, M., Shats, I., Erez, N., Tang, X., Senderovich, S., Meerson, A., Tabach, Y., Goldfinger, N., Ginsberg, D., Harris, C. C., Rotter, V.
(2003). Prolonged Culture of Telomerase-Immortalized Human Fibroblasts Leads to a Premalignant Phenotype. Cancer Res.
63: 7147-7157
[Abstract]
[Full Text]
-
Chigira, S., Sugita, K., Kita, K., Sugaya, S., Arase, Y., Ichinose, M., Shirasawa, H., Suzuki, N.
(2003). Increased Expression of the Huntingtin Interacting Protein-1 Gene in Cells From Hutchinson Gilford Syndrome (Progeria) Patients and Aged Donors. Journals of Gerontology Series A: Biological Sciences and Medical Sciences
58: B873-878
[Abstract]
[Full Text]
-
Davalos, A. R., Campisi, J.
(2003). Bloom syndrome cells undergo p53-dependent apoptosis and delayed assembly of BRCA1 and NBS1 repair complexes at stalled replication forks. JCB
162: 1197-1209
[Abstract]
[Full Text]
-
Palanca-Wessels, M. C. A., Klingelhutz, A., Reid, B. J., Norwood, T. H., Opheim, K. E., Paulson, T. G., Feng, Z., Rabinovitch, P. S.
(2003). Extended lifespan of Barrett's esophagus epithelium transduced with the human telomerase catalytic subunit: a useful in vitro model. Carcinogenesis
24: 1183-1190
[Abstract]
[Full Text]
-
Wieler, S., Gagne, J.-P., Vaziri, H., Poirier, G. G., Benchimol, S.
(2003). Poly(ADP-ribose) Polymerase-1 Is a Positive Regulator of the p53-mediated G1 Arrest Response following Ionizing Radiation. J. Biol. Chem.
278: 18914-18921
[Abstract]
[Full Text]
-
Gorbunova, V., Seluanov, A., Pereira-Smith, O. M.
(2003). Evidence That High Telomerase Activity May Induce a Senescent-like Growth Arrest in Human Fibroblasts. J. Biol. Chem.
278: 7692-7698
[Abstract]
[Full Text]
-
Itahana, K., Zou, Y., Itahana, Y., Martinez, J.-L., Beausejour, C., Jacobs, J. J. L., van Lohuizen, M., Band, V., Campisi, J., Dimri, G. P.
(2003). Control of the Replicative Life Span of Human Fibroblasts by p16 and the Polycomb Protein Bmi-1. Mol. Cell. Biol.
23: 389-401
[Abstract]
[Full Text]
-
Huot, T. J., Rowe, J., Harland, M., Drayton, S., Brookes, S., Gooptu, C., Purkis, P., Fried, M., Bataille, V., Hara, E., Newton-Bishop, J., Peters, G.
(2002). Biallelic Mutations in p16INK4a Confer Resistance to Ras- and Ets-Induced Senescence in Human Diploid Fibroblasts. Mol. Cell. Biol.
22: 8135-8143
[Abstract]
[Full Text]
-
Condon, J., Yin, S., Mayhew, B., Word, R. A., Wright, W.E., Shay, J.W., Rainey, W. E.
(2002). Telomerase Immortalization of Human Myometrial Cells. Biol. Reprod.
67: 506-514
[Abstract]
[Full Text]
-
Maser, R. S., DePinho, R. A.
(2002). Connecting Chromosomes, Crisis, and Cancer. Science
297: 565-569
[Abstract]
[Full Text]
-
Marcotte, R., Wang, E.
(2002). Replicative Senescence Revisited. Journals of Gerontology Series A: Biological Sciences and Medical Sciences
57: B257-269
[Abstract]
[Full Text]
-
Roques, C. N., Boyer, J. C., Farber, R. A.
(2001). Microsatellite Mutation Rates Are Equivalent in Normal and Telomerase-immortalized Human Fibroblasts. Cancer Res.
61: 8405-8407
[Abstract]
[Full Text]
-
Pritchard, D. E., Ceryak, S., Ha, L., Fornsaglio, J. L., Hartman, S. K., O'Brien, T. J., Patierno, S. R.
(2001). Mechanism of Apoptosis and Determination of Cellular Fate in Chromium(VI)-exposed Populations of Telomerase-immortalized Human Fibroblasts. Cell Growth Differ.
12: 487-496
[Abstract]
[Full Text]
-
Ford, L. P., Suh, J. M., Wright, W. E., Shay, J. W.
(2000). Heterogeneous Nuclear Ribonucleoproteins C1 and C2 Associate with the RNA Component of Human Telomerase. Mol. Cell. Biol.
20: 9084-9091
[Abstract]
[Full Text]
-
Meyerson, M.
(2000). Role of Telomerase in Normal and Cancer Cells. JCO
18: 2626-2634
[Abstract]
[Full Text]
-
Reddel, R. R.
(2000). The role of senescence and immortalization in carcinogenesis. Carcinogenesis
21: 477-484
[Abstract]
[Full Text]
-
LIU, J.-P.
(1999). Studies of the molecular mechanisms in the regulation of telomerase activity. FASEB J.
13: 2091-2104
[Abstract]
[Full Text]